Clinical Trials in Boston

Showing 12061-12080 of 17,836 trials

Safety Evaluation of 3K3A-APC in Ischemic Stroke

NCT02222714

The purpose of this study was to evaluate the safety, pharmacokinetics (PK) and preliminary efficacy of multiple ascending intravenous doses of 3K3A-APC, a Recombinant Variant of Human activated protein C (APC), in in the treatment of acute ischemic stroke following treatment with recombinant tissue plasminogen activator (tPA), mechanical thrombectomy or both.

Ischemic Stroke

ZZ Biotech, LLC110 participantsStarted Oct 2014

Los Angeles, California, United States • Chicago, Illinois, United States • Kansas City, Kansas, United States +12 more locations

UNKNOWNNA< 1 mile

Safety Evaluation of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Stroke

NCT03499210

A multi-site, interventional, non-comparative, single-arm trial to evaluate the safety of the ReWalk ReStore device in subjects with hemiplegia/hemiparesis due to ischemic or hemorrhagic stroke.

StrokeStroke, AcuteStroke Hemorrhagic+3 more

ReWalk Robotics, Inc.40 participantsStarted Mar 2018

Chicago, Illinois, United States • Boston, Massachusetts, United States • West Orange, New Jersey, United States +2 more locations

Safety Evaluation of 3K3A-APC in Ischemic Stroke

Safety Evaluation of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Stroke

Find Trials by Condition in Boston

Women Veterans' Substance Abuse Treatment

Pharmacogenomics for Antidepressant Guidance and Education

Avastin and Taxotere for Esophagogastric Cancer

Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

Premenstrual Dysphoric Disorder and Antiepileptic Drugs

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

Dismantling Mindfulness: Contributions of Attention vs. Acceptance

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

A Study of Enzastaurin in Participants With Follicular Lymphoma

Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Validation Study of the SAGIT® Instrument in Acromegaly